Missouri judge approves Bayer's $7.25 billion Roundup settlement
A Missouri judge has approved Bayer's proposal to pay up to $7.25 billion to resolve tens of thousands of US lawsuits over its Roundup weedkiller, Bloomberg reported on Friday, a key step in the company's effort to contain its legal costs.

Bloomberg said the judge approved the deal on Friday. The settlement covers people who say exposure to Roundup caused non-Hodgkin lymphoma, and it is meant to cover both current plaintiffs and people exposed earlier who are diagnosed later. Bayer inherited the litigation through its 2018 purchase of Monsanto.
The same court in St. Louis granted preliminary approval in March. A hearing on final approval was held on September 14, and Bayer said at the time that the number of opt-outs would be confirmed only once the court ruled. A federal judge in June sent the case back to state court after objecting plaintiffs tried to move it.
Some plaintiff firms, representing roughly 20,000 claimants, opposed the deal. They argue the payouts are too low and that the class structure would stop people from suing individually. Bayer has the right to terminate the agreement if participation falls short.
Bayer says Roundup is safe when used as directed. The company has said the settlement is intended to limit future liabilities. The terms provide for payments over 21 years.
A separate question, whether federal law pre-empts failure-to-warn claims against the weedkiller, was before the US Supreme Court this year.



